Marta Larrayoz Ilundain

9PUBLICATIONS
85CO-AUTHORS
Medical mycologyGene and molecular therapyPredictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 23, 2026
Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response.

|Dec 19, 2025
Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma.

Francesco Maura, Ciara L Freeman, Kylee H Maclachlan

|Feb 23, 2025
Phosphatidylserine as a tumor target for CAR-T cell therapy.

Celia Martín-Otal, Inés Sánchez-Moreno, Alvaro Gómez-Morón

|Sep 24, 2024
Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cells.

Sarah Staudt, Fabian Nikolka, Markus Perl

|Sep 20, 2023
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.

Cirino Botta, Cristina Perez, Marta Larrayoz

|Mar 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.

Marta Larrayoz, Maria J Garcia-Barchino, Jon Celay

Pageof 2

Frequent Collaborators

5 joint publications

Felipe Prosper

4 joint publications

Jon Celay

4 joint publications

Bruno Paiva

4 joint publications

Jose-Angel Martinez-Climent